Feasibility of the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant Program: A Group-Based Lifestyle Intervention and GLP-1 Receptor Agonist Therapy for End-Stage Kidney Disease Candidates Ineligible Due to Obesity

Evan M. Sisson, Dana Burns, Sarah E. Wheeler, Keerthana Akkisetty, Johanna L. Christensen, Gaurav Gupta

Open source

DOI
10.1177/26350106261483738
Published
2026-09-26
Container
The Science of Diabetes Self-Management and Care
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/26350106261483738,
  title = {Feasibility of the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant Program: A Group-Based Lifestyle Intervention and GLP-1 Receptor Agonist Therapy for End-Stage Kidney Disease Candidates Ineligible Due to Obesity},
  author = {Evan M. Sisson and Dana Burns and Sarah E. Wheeler and Keerthana Akkisetty and Johanna L. Christensen and Gaurav Gupta},
  year = {2026},
  journal = {The Science of Diabetes Self-Management and Care},
  doi = {10.1177/26350106261483738},
  url = {https://doi.org/10.1177/26350106261483738}
}

RIS

TY  - JOUR
TI  - Feasibility of the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant Program: A Group-Based Lifestyle Intervention and GLP-1 Receptor Agonist Therapy for End-Stage Kidney Disease Candidates Ineligible Due to Obesity
AU  - Evan M. Sisson
AU  - Dana Burns
AU  - Sarah E. Wheeler
AU  - Keerthana Akkisetty
AU  - Johanna L. Christensen
AU  - Gaurav Gupta
PY  - 2026
JO  - The Science of Diabetes Self-Management and Care
DO  - 10.1177/26350106261483738
UR  - https://doi.org/10.1177/26350106261483738
ER  - 

APA

Sisson, E. M., Burns, D., Wheeler, S. E., Akkisetty, K., Christensen, J. L., & Gupta, G. (2026). Feasibility of the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant Program: A Group-Based Lifestyle Intervention and GLP-1 Receptor Agonist Therapy for End-Stage Kidney Disease Candidates Ineligible Due to Obesity. The Science of Diabetes Self-Management and Care. https://doi.org/10.1177/26350106261483738

Source records